14 -8 (58) 2023 — Yusupov A.F., Jamalova Sh.A. — COMPARATIVE ASSESSMENT OF THE DYNAMICS OF THE PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS AFTER COVID-19

COMPARATIVE ASSESSMENT OF THE DYNAMICS OF THE PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS AFTER COVID-19

Yusupov A.F., Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery

Jamalova Sh.A., Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery

Mahmudov N.Kh. Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery

Resume

The purpose of the study was assessment of the degree of progression of diabetic retinopathy (DR) in patients who have had a coronavirus infection. Methods. A retrospective and prospective analysis of the severity of DR was performed in 84 patients with type 2 diabetes mellitus who underwent COVID-19. Based on a comparative analysis of the dynamics of the disease during the pandemic (2020-2021) and the “pre-pandemic period” (2018-2019). Results. In persons who underwent COVID-19, the progression of the stages of non-proliferative retinopathy prevailed. In most cases, there was a transition from the mild stage of non-proliferative retinopathy to moderate and moderate to severe. Conclusion. Postponed COVID-19 contributes to a significant progression in the form of an increase in the level of the non-proliferative stage of DR

Keywords: COVID-19; diabetic retinopathy; progression.

First page

81

Last page

84

For citation: Yusupov A.F., Jamalova Sh.A.,Mahmudov N.Kh. – COMPARATIVE ASSESSMENT OF THE DYNAMICS OF THE PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS AFTER COVID-19 2023 8(58): 81-84 https://newdaymedicine.com/index.php/2023/08/16/l-302/

LIST OF REFERENCES:

1. Артыкбаева Г.М., Саатов Т.С. Взаимосвязь тяжелого острого респираторного синдрома, вызванного вирусом SARS-CoV-2, и сахарного диабета (обзор литературы). // Сахарный диабет. 2023;26(1):66-74.
2. Ахметшин Р.Ф., Ризванов А.А., Булгар С.Н. и др. Коронавирусная инфекция и офтальмология. // Казанский медицинский журнал. 2020;101(3):371-80.
3. Илларионова А.Р., Потапова О.М., Косарева О.А., Кузнецова Ю.Р. Частота ретинальных изменений у пациентов, перенесших заболевание COVID-19: обсервационное исследование. // Сеченовский вестник. 2020;11(2):40-49.
4. Курчатова Н.Н., Галимова Л.Ф., Мударисова И.Т., Назмутдинов Б.Р. Особенности иммунного статуса пациентки с диабетической непролиферативной ретинопатией после перенесенного COVID-19. // Медицинский вестник Башкортостана. 2021;16(4(94):49-53.
5. Ahmed I., Liu T.Y.A. The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment. // Curr Diab Rep. 2021;21(10):40.
6. Al-Dwairi R., Rwashdeh H., Otoom M. The Influence of COVID-19 Lockdown in Jordan on Patients with Diabetic Retinopathy: A Case-Control Study. //Ther Clin Risk Manag. 2021;17:1011-1022.
7. Bertoli F., Veritti D., Danese C., et al. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye //J Ophthalmol. 2020;4(82):73-104.
8. Boden I., Bernabeu M.O., Dhillon B. et al. Pre-existing diabetic retinopathy as a prognostic factor for COVID-19 outcomes amongst people with diabetes: A systematic review. // Diabetes Res Clin Pract. 2022;187:109-869.